BRISTOL, Tenn., May 2 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. today announced that a live audio webcast of its presentation scheduled for Thursday, May 4, 2006, at 3:45 p.m., Eastern Daylight Time, at the Morgan Stanley Global Healthcare Unplugged Conference at the Mandarin Oriental Hotel in Miami, Florida may be accessed via the internet. Interested persons may access the webcast on the King Pharmaceuticals website at http://www.kingpharm.com/web_casts.asp. After the event, a replay of the webcast may be accessed through Thursday, May 18, 2006 at the same URL. This corrects an earlier release which incorrectly stated the time for the webcast.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
Forward-looking Statements
This release contains forward-looking statements which reflect management’s current views of future events and operations, including, but not limited to, statements pertaining to the anticipated audio webcast of the Company’s presentation on May 4, 2006. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. An important factor which may cause results to differ is whether King is able to webcast the audio portion of the presentation on May 4, 2006 as currently planned. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.
King Pharmaceuticals, Inc.
CONTACT: James E. Green, Executive Vice President, Corporate Affairs,+1-423-989-8125, or David E. Robinson, Sr. Director, Corporate Affairs,+1-423-989-7045, both of King Pharmaceuticals, Inc.
Company News On-Call: http://www.prnewswire.com/comp/120319.html/
